Gray Wolf Reintroduction in Colorado Encounters Federal Kerfuffle

This month, voters in the state approved the predators’ reintroduction, but the species’ recent delisting as an endangered species at the federal level binds up available funding.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, HKUCHERA

Mere days before voters in Colorado this month approved the reintroduction of gray wolves into the wild, the US Department of the Interior announced that wolf numbers had recovered and would no longer receive federal protection under the Endangered Species Act as of January 4, 2021. Although lawsuits will be filed in the next month or so to reverse DOI’s decision, delisting would have both positive and negative consequences on reintroduction efforts.

According to the wording of the state’s Proposition 114, Colorado Parks and Wildlife Commission would be responsible for devising a reintroduction plan for the wolves and would need to begin carrying it out before December 31, 2023, along with compensating farmers for lost livestock. According to NPR, this was the first time any state had planned to take individual action on an endangered species. This in itself sparked debate about who should be in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Lisa Winter

    Lisa Winter became social media editor for The Scientist in 2017. In addition to her duties on social media platforms, she also pens obituaries for the website. She graduated from Arizona State University, where she studied genetics, cell, and developmental biology.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide